Re: "Botulinum toxin type A as a migraine preventive treatment" (Silberstein S, Mathew N, Saper J, Jenkins S, for the BOTOX Migraine Clinical Research Group. Headache. 2000;40:445-450).
Zlotnik
G
G
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D004644:Emotions; D005152:Facial Muscles / Q000187:drug effects*; D005246:Feedback / Q000187:drug effects; D006801:Humans; D007267:Injections; D008881:Migraine Disorders / Q000517:prevention & control*; D008954:Models, Biological; D009465:Neuromuscular Agents / Q000627:therapeutic use*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A